- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
- FREE CONSULTATION & SHIPPING
- NEWEST WEIGHT LOSS PEPTIDE: RETATRUTIDE
- A NEW ERA OF HEALTH, BORN IN THE PHILIPPINES
Mitochondria-Targeting Peptide · Educational Resource
Understanding SS-31 and Mitochondrial Function Research
Peptide Classification
Synthetic tetrapeptide (Szeto-Schiller peptide), mitochondria-targeting
Target Application in Literature
Investigational mitochondrial function and cellular energy research
Administration Protocol in Studies
Subcutaneous (subq) pen delivery
Want to learn more?
A licensed team will reach out to guide you through the research.
Book a consultation →Mitochondria-Targeting Peptide · Educational Resource
Understanding SS-31 and Mitochondrial Function Research
01 — Overview
What is SS-31?
SS-31 (also studied under the name elamipretide) is a synthetic tetrapeptide engineered to selectively concentrate in the inner mitochondrial membrane, studied for its potential role in supporting mitochondrial structure and function.
To understand its biological role, it helps to think of mitochondria as the cell's power plants, with an intricately folded inner membrane (the cristae) that maximizes energy production. SS-31 is studied for its capacity to bind directly to this membrane and help preserve its folded structure under stress.
Scientific literature categorizes SS-31 as an investigational compound. By selectively targeting mitochondrial membranes, researchers can study cellular energy production and oxidative stress pathways under controlled laboratory conditions.
02 — How it works
How It Works: Cardiolipin Binding and Cristae Stabilization
The primary mechanism researchers evaluate when studying SS-31 is its capacity to bind to cardiolipin, a phospholipid unique to the inner mitochondrial membrane, helping stabilize the cristae folds where the electron transport chain operates.
Because cristae stability is linked to more efficient ATP production and reduced generation of reactive oxygen species (ROS), studies also evaluate SS-31's associations with reduced oxidative stress and improved mitochondrial function in aging and stressed tissue models.
Administration in Research
In modern observational studies and laboratory applications, delivery methodologies focus exclusively on the use of a subq pen (subcutaneous delivery). This delivery system is prioritized in current protocols because it allows for precise, localized, and highly controlled micro-dosing directly into the subcutaneous layer to observe systemic mitochondrial function effects.
03 — Areas of research
Summary of Investigated Research Areas
Ongoing preclinical and clinical studies evaluate SS-31 across several key physiological systems, particularly relating to mitochondrial cristae structure, oxidative stress reduction, and cellular energy metabolism.
Mitochondrial Cristae Stabilization
Clinical literature evaluates SS-31's binding to cardiolipin and its role in preserving mitochondrial inner membrane structure.
Oxidative Stress Reduction
Studies examine SS-31's association with reduced reactive oxygen species generation in stressed mitochondria.
Cardiac Function Research
Clinical trials evaluate elamipretide's effect on cardiac mitochondrial function and heart failure-related outcomes.
Skeletal Muscle Performance in Aging
Research explores SS-31's studied effect on muscle energetics and performance in aged animal models.
Ischemia-Reperfusion Injury Research
Investigations evaluate mitochondria-targeting peptides' potential role in reducing tissue damage following ischemic events.
Cellular Energy Metabolism
Studies assess SS-31's broader association with ATP production efficiency across various tissue types.
04 — FAQ
Frequently Asked Questions
05 — References
References and Academic Literature
Szeto, H. H. (2014). First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.. British Journal of Pharmacology, 171(8), 2029-2050.
Daubert, M. A., Yow, E., Dunn, G., et al. (2017). Novel Mitochondria-Targeting Peptide in Heart Failure Treatment: A Randomized, Placebo-Controlled Trial of Elamipretide.. Circulation: Heart Failure, 10(12), e004389.
Siegel, M. P., Kruse, S. E., Percival, J. M., et al. (2013). Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice.. Aging Cell, 12(5), 763-771.
i
Medical Education Disclaimer: This page is intended strictly for educational and informational purposes regarding the scientific history and development of chemical compounds. It does not constitute medical advice, promotion, or advertising of any prescription medication. Any therapeutic applications must be evaluated and managed exclusively by a licensed medical practitioner.
Getting started
How to Get Started?
1. Consult
Book a free consultation with our licensed healthcare team.
100 % online. Hassle-free. Convenient.
2. Real Human Assessment
Talk with Philippine-licensed doctors and get prescribed.
Always doctor-led—never just an online form.
Free consultation with licensed providers
3. Start your Program
Your medication is prepared and delivered to your doorstep.
No lock-ins. No hidden fees. No subscriptions.
Formulated in FDA-regulated pharmacies
4. Consistent care
Stay on track with regular weekly follow-ups. On your chosen communication platform.
Unlimited complementary follow-ups
